|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2005-6-29
|
|
pubmed:abstractText |
In the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Trial, the use of abciximab in patients undergoing percutaneous coronary intervention (PCI) after pretreatment with 600 mg clopidogrel for >2 h was associated with no clinically measurable benefit at 30 days. We assessed whether there was any clinical benefit from abciximab at 1 year follow-up.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
pubmed-author:BergerPeter BPB,
pubmed-author:DibraAlbanA,
pubmed-author:DirschingerJosefJ,
pubmed-author:DotzerFranzF,
pubmed-author:Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action...,
pubmed-author:KastratiAdnanA,
pubmed-author:MehilliJulindaJ,
pubmed-author:NeumannFranz-JosefFJ,
pubmed-author:RodriguesJorge L MJL,
pubmed-author:SchömigAlbertA,
pubmed-author:SchühlenHelmutH,
pubmed-author:SchmittClausC,
pubmed-author:ten BergJurriën MJM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1379-84
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15734767-Aged,
pubmed-meshheading:15734767-Angina, Unstable,
pubmed-meshheading:15734767-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15734767-Antibodies, Monoclonal,
pubmed-meshheading:15734767-Anticoagulants,
pubmed-meshheading:15734767-Death, Sudden, Cardiac,
pubmed-meshheading:15734767-Disease-Free Survival,
pubmed-meshheading:15734767-Double-Blind Method,
pubmed-meshheading:15734767-Female,
pubmed-meshheading:15734767-Follow-Up Studies,
pubmed-meshheading:15734767-Humans,
pubmed-meshheading:15734767-Immunoglobulin Fab Fragments,
pubmed-meshheading:15734767-Male,
pubmed-meshheading:15734767-Middle Aged,
pubmed-meshheading:15734767-Myocardial Infarction,
pubmed-meshheading:15734767-Myocardial Revascularization,
pubmed-meshheading:15734767-Platelet Aggregation Inhibitors,
pubmed-meshheading:15734767-Risk Factors,
pubmed-meshheading:15734767-Stents,
pubmed-meshheading:15734767-Ticlopidine,
pubmed-meshheading:15734767-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
|
|
pubmed:affiliation |
Deutsches Herzzentrum, Lazarettstr. 36, 80636 Munich, Germany. aschoemig@dhm.mhn.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
